Alkermes plc Előre P/E

Mi az Alkermes plc Előre P/E?

A Előre P/E az Alkermes plc - 20.22

Mi a Előre P/E meghatározása?

Az előrejelzett ár / jövedelem arány a vállalat tőzsdei árának és a társaság becsült részvényenkénti eredményének aránya a következő tizenkét hónapban.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Mit csinál Alkermes plc?

alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.

előre p/e -hoz hasonló cégek Alkermes plc

Universal Health Services nak Előre P/E 20.20 van
Tractor Supply nak Előre P/E 20.20 van
Dolby Laboratories nak Előre P/E 20.20 van
RELX Plc nak Előre P/E 20.20 van
KEC International nak Előre P/E 20.20 van
Cadila Healthcare nak Előre P/E 20.20 van
Alkermes plc nak Előre P/E 20.22 van
Atmos nak Előre P/E 20.23 van
Chamberlin plc nak Előre P/E 20.24 van
Trident nak Előre P/E 20.24 van
Altabancorp nak Előre P/E 20.24 van
Ingenico SA nak Előre P/E 20.24 van
Mastec nak Előre P/E 20.24 van